162 related articles for article (PubMed ID: 20529086)
21. Autoantibodies in relation to residual insulin secretion in children with IDDM.
Ludvigsson J; Hellström S
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):81-9. PubMed ID: 9179462
[TBL] [Abstract][Full Text] [Related]
22. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
[TBL] [Abstract][Full Text] [Related]
23. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
[TBL] [Abstract][Full Text] [Related]
24. [Plasma levels of interleukin-1beta, interleukin-2 and interleukin-4 in recently diagnosed type 1 diabetic children and their association with beta-pancreatic autoantibodies].
Pérez F; Oyarzún A; Carrasco E; Angel B; Albala C; Santos JL
Rev Med Chil; 2004 Apr; 132(4):413-20. PubMed ID: 15382512
[TBL] [Abstract][Full Text] [Related]
25. [The changes of serum interferon-inducible protein-10 levels in children with type 1 diabetes mellitus].
Xin Y; Zhao YQ; Zhao YX; Zhang LH
Zhonghua Er Ke Za Zhi; 2007 Nov; 45(11):853-5. PubMed ID: 18282420
[TBL] [Abstract][Full Text] [Related]
26. CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes.
Schölin A; Siegbahn A; Lind L; Berne C; Sundkvist G; Björk E; Karlsson FA;
Diabetes Metab Res Rev; 2004; 20(3):205-10. PubMed ID: 15133751
[TBL] [Abstract][Full Text] [Related]
27. Association between autoantibodies to the Arginine variant of the Zinc transporter 8 (ZnT8) and stimulated C-peptide levels in Danish children and adolescents with newly diagnosed type 1 diabetes.
Andersen ML; Vaziri-Sani F; Delli A; Pörksen S; Jacobssen E; Thomsen J; Svensson J; Steen Petersen J; Hansen L; Lernmark A; Mortensen HB; Nielsen LB
Pediatr Diabetes; 2012 Sep; 13(6):454-62. PubMed ID: 22686132
[TBL] [Abstract][Full Text] [Related]
28. An association of autoantibody status and serum cytokine levels in type 1 diabetes.
Hanifi-Moghaddam P; Schloot NC; Kappler S; Seissler J; Kolb H
Diabetes; 2003 May; 52(5):1137-42. PubMed ID: 12716743
[TBL] [Abstract][Full Text] [Related]
29. Islet cell autoantibody levels after the diagnosis of young adult diabetic patients.
Jensen R; Gilliam L; Torn C; Landin-Olsson M; Palmer J; Akesson K; Kockum I; Lernmark B; Karlsson AF; Lynch KF; Breslow N; Lernmark A; Sundkvist G;
Diabet Med; 2007 Nov; 24(11):1221-8. PubMed ID: 17725633
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.
Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M
Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935
[TBL] [Abstract][Full Text] [Related]
31. Childhood thyroid autoimmunity and relation to islet autoantibodies in children at risk for type 1 diabetes in the diabetes prediction in skåne (DiPiS) study.
Jonsdottir B; Larsson C; Lundgren M; Ramelius A; Jönsson I; Larsson HE;
Autoimmunity; 2018 Aug; 51(5):228-237. PubMed ID: 30486698
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of slow progression to diabetes in multiple islet autoantibody-positive individuals from five longitudinal cohorts: the SNAIL study.
Long AE; Wilson IV; Becker DJ; Libman IM; Arena VC; Wong FS; Steck AK; Rewers MJ; Yu L; Achenbach P; Casas R; Ludvigsson J; Williams AJK; Gillespie KM
Diabetologia; 2018 Jun; 61(6):1484-1490. PubMed ID: 29532109
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.
Alves LI; Davini E; Correia MR; Fukui RT; Santos RF; Cunha MR; Rocha DM; Volpini WM; Silva ME
J Clin Immunol; 2012 Aug; 32(4):778-85. PubMed ID: 22402866
[TBL] [Abstract][Full Text] [Related]
34. The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients.
Liu J; Bian L; Ji L; Chen Y; Chen H; Gu Y; Ma B; Gu W; Xu X; Shi Y; Wang J; Zhu D; Sun Z; Ma J; Jin H; Shi X; Miao H; Xin B; Zhu Y; Zhang Z; Bu R; Xu L; Shi G; Tang W; Li W; Zhou D; Liang J; Cheng X; Shi B; Dong J; Hu J; Fang C; Zhong S; Yu W; Lu W; Wu C; Qian L; Yu J; Gao J; Fei X; Zhang Q; Wang X; Cui S; Cheng J; Xu N; Wang G; Han G; Xu C; Xie Y; An M; Zhang W; Wang Z; Cai Y; Fu Q; Fu Y; Zheng S; Yang F; Hu Q; Dai H; Jin Y; Zhang Z; Xu K; Li Y; Shen J; Zhou H; He W; Zheng X; Han X; Yu L; She J; Zhang M; Yang T
Sci China Life Sci; 2016 Sep; 59(9):930-9. PubMed ID: 27225179
[TBL] [Abstract][Full Text] [Related]
35. Prediction of type 1 diabetes in Sardinian schoolchildren using islet cell autoantibodies: 10-year follow-up of the Sardinian schoolchildren type 1 diabetes prediction study.
Velluzzi F; Secci G; Sepe V; Klersy C; Shattock M; Foxon R; Songini M; Mariotti S; Locatelli M; Bottazzo GF; Loviselli A;
Acta Diabetol; 2016 Feb; 53(1):73-9. PubMed ID: 25896008
[TBL] [Abstract][Full Text] [Related]
36. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
[TBL] [Abstract][Full Text] [Related]
37. DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes.
Bansal N; Hampe CS; Rodriguez L; O'Brian Smith E; Kushner J; Balasubramanyam A; Redondo MJ
Diabet Med; 2017 May; 34(5):641-646. PubMed ID: 26802570
[TBL] [Abstract][Full Text] [Related]
38. The association of adiponectin and low-grade inflammation with the course of metabolic syndrome.
Ahonen TM; Saltevo JT; Kautiainen HJ; Kumpusalo EA; Vanhala MJ
Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):285-91. PubMed ID: 21093230
[TBL] [Abstract][Full Text] [Related]
39. Adiponectin, biomarkers of inflammation and changes in cardiac autonomic function: Whitehall II study.
Hansen CS; Vistisen D; Jørgensen ME; Witte DR; Brunner EJ; Tabák AG; Kivimäki M; Roden M; Malik M; Herder C
Cardiovasc Diabetol; 2017 Dec; 16(1):153. PubMed ID: 29195493
[TBL] [Abstract][Full Text] [Related]
40. Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus--a nationwide study.
Ostman J; Landin-Olsson M; Törn C; Palmer J; Lernmark A; Arnqvist H; Björk E; Bolinder J; Blohmé G; Eriksson J; Littorin B; Nyström L; Scherstén B; Sundkvist G; Wibell L
Diabet Med; 2000 Apr; 17(4):269-74. PubMed ID: 10821292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
